| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Revenue | $90K | +0.0% |
| R&D Expense | $17.7M | +44.2% |
| SG&A Expense | $11.8M | +19.5% |
| Operating Income | -$33.3M | -41.6% |
| Interest Expense | $11K | +0.0% |
| Pre-tax Income | -$33.1M | -43.4% |
| Income Tax | $576K | — |
| Net Income | -$33.6M | -45.9% |
| EPS (Basic) | -$0.23 |
| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $41.7M | -40.5% |
| Current Assets | $44.6M | -38.8% |
| Total Assets | $114.0M | -20.0% |
| Current Liabilities | $4.5M | +13.8% |
| Total Liabilities | $10.6M | +9.6% |
| Stockholders' Equity | $102.8M | -22.2% |
| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$28.4M | -17.0% |
| Capital Expenditures | $7K | +0.0% |
| Investing Cash Flow | -$40.0M | +0.0% |
| Financing Cash Flow | $120.5M | +0.0% |
| Free Cash Flow | -$28.4M | -16.9% |
| +0.0% |
| EPS (Diluted) | -$0.23 | +0.0% |